BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2564799)

  • 1. Effect of phorbol esters on noradrenaline release from cerebral arteries.
    Balfagon G; Rosa de Sagarra M; Barrus MT; Arrivas S; Capilla MI; Marin J
    Brain Res; 1989 Jan; 477(1-2):196-201. PubMed ID: 2564799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C activation and alpha 2-autoreceptor-modulated release of noradrenaline.
    Allgaier C; Hertting G; Huang HY; Jackisch R
    Br J Pharmacol; 1987 Sep; 92(1):161-72. PubMed ID: 2822193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of noradrenaline release in human cerebral arteries via presynaptic alpha 2-adrenoceptors.
    Sanchez-Merino JA; Arribas S; Arranz A; Marín J; Balfagón G
    Gen Pharmacol; 1990; 21(6):859-62. PubMed ID: 1980655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the subtype of presynaptic alpha 2-adrenoceptors modulating noradrenaline release in cat and bovine cerebral arteries.
    Arribas S; Galvan R; Ferrer M; Herguido MJ; Marin J; Balfagón G
    J Pharm Pharmacol; 1991 Dec; 43(12):855-9. PubMed ID: 1687585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural requirements for phorbol esters to enhance noradrenaline and dopamine release from rat brain cortex.
    Kotsonis P; Majewski H
    Br J Pharmacol; 1996 Sep; 119(1):115-25. PubMed ID: 8872364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C activation increases noradrenaline release from the rat hippocampus and modifies the inhibitory effect of alpha 2-adrenoceptor and adenosine A1-receptor agonists.
    Fredholm BB; Lindgren E
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):477-83. PubMed ID: 2842695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]5-hydroxytryptamine uptake and release in cat cerebral arteries.
    Barrús MT; Balfagón G; Salaíces M; Marín J
    Gen Pharmacol; 1990; 21(2):189-94. PubMed ID: 2332139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C and alpha 2-adrenoceptor-mediated inhibition of noradrenaline release from the rat tail artery.
    Bucher B; Neuburger J; Illes P
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):913-5. PubMed ID: 1714014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells.
    Murphy NP; McCormack JG; Ball SG; Vaughan PF
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):645-50. PubMed ID: 1554348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of protein kinase C and regulatory G proteins in modulation of the evoked noradrenaline release in brain.
    Hertting G; Allgaier C
    Cell Mol Neurobiol; 1988 Mar; 8(1):105-14. PubMed ID: 2841025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of [3H]-noradrenaline from the sympathetic nerves to bovine mesenteric lymphatic vessels and its modification by alpha-agonists and antagonists.
    Allen JM; McCarron JG; McHale NG; Thornbury KD
    Br J Pharmacol; 1988 Jul; 94(3):823-33. PubMed ID: 2902893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of alpha 2-adrenoceptors and protein kinase C on nicotine-induced facilitation of noradrenaline release in bovine cerebral arteries.
    Sánchez-Merino JA; Marín J; Balfagón G; Ferrer M
    Gen Pharmacol; 1995 Jul; 26(4):827-33. PubMed ID: 7635258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of noradrenaline release from cat cerebral arteries by presynaptic alpha 2-adrenoceptors. Effect of chronic treatment with desipramine and cocaine.
    Balfagón G; Marín J
    Gen Pharmacol; 1989; 20(3):289-94. PubMed ID: 2545507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field stimulation-induced noradrenaline release from guinea-pig atria is modulated by prejunctional alpha 2-adrenoceptors and protein kinase C.
    Brasch H
    Basic Res Cardiol; 1993; 88(6):545-56. PubMed ID: 8147820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of noradrenaline release by 12-O-tetradecanoyl phorbol-13-acetate, an activator of protein kinase C.
    Allgaier C; Von Kügelgen O; Hertting G
    Eur J Pharmacol; 1986 Oct; 129(3):389-92. PubMed ID: 3780850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclassification of release-regulating alpha 2-autoreceptors in human brain cortex.
    Raiteri M; Bonanno G; Maura G; Pende M; Andrioli GC; Ruelle A
    Br J Pharmacol; 1992 Dec; 107(4):1146-51. PubMed ID: 1361400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of calcium-dependent [3H]noradrenaline release from rat cerebrocortical synaptosomes by protein kinase C and modulation of the actin cytoskeleton.
    Walaas SI
    Neurochem Int; 1999 Mar; 34(3):221-33. PubMed ID: 10355489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phorbol esters and polymyxin B on modulation of noradrenaline release in mouse atria.
    Musgrave IF; Majewski H
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):48-53. PubMed ID: 2542807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of activation or inhibition of protein kinase C on the release of radioactivity from rat isolated atria labelled with [3H]-noradrenaline.
    Ishac EJ; De Luca A
    Br J Pharmacol; 1988 Jul; 94(3):713-20. PubMed ID: 3179609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.